Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emerald Health Therapeutics Inc TBQBF


Primary Symbol: EMHTF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.


OTCQB:EMHTF - Post by User

Emerald Health Therapeutics Inc > Citron report
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(35)
•••
Comment by Looneeon Jun 19, 2019 10:28pm
185 Views
Post# 29842521

RE:RE:Citron report

RE:RE:Citron reportYes, looks like market is targets 52 wk low here now, low $2s. Gold on a tear and may be seeing money flowing back to precious metals sector. I sold out of EMH for a loss at $3.65, didn't like GMP selling so much since before Citron and after, to raise $10M for EMH over 3 months. Sure has benefits vs a placement (still paid them $250k for selling new stock) but having to compete with the company for a sale sucked. Red flags too. Soured on cannabis now in any event. GLTA.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities